Leveraging 13 Years of Investment in mRNA Innovation for Future Pandemic Preparedness
May 24, 2023
By: Hamilton Bennett, Senior Director of Vaccine Access and Partnerships
At Moderna, we know what it means to push past possible – especially when talking about time to response. Just two days after the first complete sequence of the COVID-19 virus was made publicly available online in January of 2020, Moderna's COVID-19 vaccine candidate was under development. Today, it’s been approved in more than 70 countries. While I am proud of the impact Moderna had in ending this pandemic, we must not lose sight of the millions of lives lost over the last three years. Unfortunately, COVID-19 will not be our last pandemic, but the lessons that can be learned will help us better prepare for the next one.